Loading organizations...
Key people at Forge Life Science Partners.
Key people at Forge Life Science Partners.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 10, 2026 | Kinaset Therapeutics | $103.0M Series B | Anand Mehra, Henry Stusnick | 5AM Ventures, Atlas Venture, Bram Vanparys, PhD, MBA, Daniela Begolo, Pictet Alternative Advisors, Schroders Capital, Sixty Degree Capital, Vivo Capital, Willett Advisors |
| Jan 1, 2024 | OnCusp Therapeutics | $100.0M Series A | Novo Ventures, OrbiMed, Chong Xu | F-Prime Capital Partners, Blackbird BioVentures, Catalio Capital Management, Marshall Wace, Sofinnova Ventures |
| Nov 1, 2022 | Escient Pharmaceuticals | $120.0M Series C | Abingworth, Forge Life Science Partners, NEA | 5AM Ventures, Access Biotechnology, Atlas Venture, Carol Gallagher, Robert Garland, Nextech Invest, OrbiMed, Osage University Partners, Sanofi Ventures, The Column Group, Altitude Life Science Ventures, Avego Bioscience Capital, Cowen Healthcare Investments, PFM Health Sciences, Redmile Group, The Eleven Fund |